1. Home
  2. VNT vs IRTC Comparison

VNT vs IRTC Comparison

Compare VNT & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vontier Corporation

VNT

Vontier Corporation

HOLD

Current Price

$42.57

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$148.49

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNT
IRTC
Founded
2019
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.8B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
VNT
IRTC
Price
$42.57
$148.49
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$46.11
$217.31
AVG Volume (30 Days)
1.1M
869.4K
Earning Date
02-12-2026
02-19-2026
Dividend Yield
0.24%
N/A
EPS Growth
4.02
N/A
EPS
2.73
N/A
Revenue
$3,043,900,000.00
$702,573,000.00
Revenue This Year
$2.79
$27.50
Revenue Next Year
$2.25
$17.10
P/E Ratio
$15.45
N/A
Revenue Growth
1.76
25.45
52 Week Low
$27.22
$92.52
52 Week High
$43.88
$212.00

Technical Indicators

Market Signals
Indicator
VNT
IRTC
Relative Strength Index (RSI) 75.71 37.76
Support Level $36.40 $145.42
Resistance Level $40.76 $162.27
Average True Range (ATR) 1.21 6.71
MACD 0.53 -0.89
Stochastic Oscillator 94.26 15.47

Price Performance

Historical Comparison
VNT
IRTC

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: